Target intelligence / Profile preview

Adenosylmethionine decarboxylase 1 pseudogene 3 (AMD1P3)

Target: AMD1P3
Molecular classification: Other (Pseudogene)

Overview

Adenosylmethionine decarboxylase 1 pseudogene 3 (AMD1P3) is classified as a pseudogene in the human genome[3][2]. Pseudogenes are genomic sequences that resemble known genes but harbor mutations (such as frame-shifts, premature stop codons, or disruptions in promoter elements) that prevent them from producing functional proteins[6]. AMD1P3 was derived from the ancestral AMD1 gene, which encodes adenosylmethionine decarboxylase 1, an enzyme essential for polyamine biosynthesis in cells. As a pseudogene, AMD1P3 is considered nonfunctional at the protein level, and no specific role in human biology or disease has been attributed to this locus. Emerging studies suggest some pseudogenes may influence gene regulation in certain contexts[4][6], yet there is no functional evidence for AMD1P3. It is not recognized as a therapeutic target, biomarker, or player in disease mechanisms.

Other names: AMD1P3adenosylmethionine decarboxylase 1 pseudogene 3

Biological functions

Most pseudogenes, including AMD1P3, are not known to have canonical biological functions. Some pseudogenes can regulate gene expression via RNA-based mechanisms (e.g., acting as miRNA sponges), but there is no published evidence of AMD1P3 having such activity

Disease associations

None established. While some pseudogenes can influence cancer or other diseases via noncoding RNA mechanisms[4][6], there is no evidence for AMD1P3 having any disease association or pathogenic role

Interacting drugs

None. There are no known drugs targeting AMD1P3 or interacting with its transcript or encoded (nonfunctional) protein

Beyond the preview

Go deeper on Adenosylmethionine decarboxylase 1 pseudogene 3 (AMD1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adenosylmethionine decarboxylase 1 pseudogene 3 (AMD1P3).

Explore the full profile